Depression App Moodpath Turns One Year Old: Over 100.000 Users, more than 25.000 Electronic Referral Letters Created

MoodpathOctober 10, 2017 was the date of the World Mental Health Day. On the same day, Moodpath, the app for the early recognition of depression, has been on the market for one year. Moodpath has been downloaded by more than 100.000 users and more than 25.000 referral letters for further treatment by healthcare professionals have been created by the app. Moodpath is already the number one app for the term “depression” on the iOS App Stores in the UK, Canada, Australia, Germany, Austria, Switzerland, and the Netherlands. The user ratings are overwhelmingly positive (with an average rating of 4.7 out of 5).

The CE-certified medical app aims to improve the recognition of depression - with the help of an algorithm and the analysis of anonymous data. "To this day, 90 percent of the people affected don't get the treatment they need. According to the WHO more than 320 million people worldwide suffer from depression. And every month there are more than 30 million Google searches on this topic. There simply is no alternative to the complementary use of digital medical products like Moodpath, if we finally want to reduce the treatment gap in mental healthcare," says Felix Frauendorf, founder of Berlin-based Aurora Health, the company behind Moodpath.

The scientific validation of Moodpath is of particular importance to the founders. Three studies are currently being conducted, including one at the Free University of Berlin. Additional research projects in the United States are about to commence: "We are currently in contact with researchers and data scientists at Columbia University and Stanford. It is our goal to constantly use studies and the latest scientific findings to further develop our mobile depression screening," stresses Mark Goering, clinical psychologist and founder of Aurora Health. Moodpath will shortly expand its services to include customized daily plans. These plans are individually tailored to the needs of each user, adapt to progress made, and include psychological exercises based on cognitive behavioural therapy.

For further information, please visit:
http://www.moodpath.io

About Moodpath
Moodpath is a mobile mental health app for the detection and treatment of depression. The app includes a user-friendly screening and improvement program. Based on an algorithm the program adapts to each individual user. The app is linked to Aurora, a platform that supports mental healthcare practitioners. Moodpath connects doctors and patients with a collaborative digital infrastructure, improving efficiency, accessibility and outcome for all stakeholders in the mental healthcare system.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...